Finding the best prices at pharmacies near you...


Diabetes Mellitus

Blog Posts Related to Diabetes Mellitus:

Lilly to release half-price authorized generic of Humalog insulin

A new authorized generic of Eli Lilly’s insulin drug Humalog (insulin lispro) will soon be available in US pharmacies at half the price of the branded equivalent. The pharmaceutical giant made the announcement on March 4th 2019, asserting that the introduction of an alternative insulin option...

Read More

New Diabetes Technology, Devices & Products to Watch in 2019

Last year saw some significant steps forward in diabetes technology, with a number of new monitoring technologies and insulin delivery devices gaining US Food and Drug Administration (FDA) approval over the course of 2018. Among the new products available to American diabetes patients last year...

Read More

What To Do When Your Child Is Diagnosed With Type 1 Diabetes

For parents of children with type 1 diabetes mellitus the diagnosis often comes as a bolt from the blue. There is always a huge amount of information to digest and process and it’s easy to feel overwhelmed by the sudden influx of information on medications, blood glucose testing, dietary...

Read More

Take Control of Your Diabetes Management Plan

A diabetes diagnosis may seem overwhelming at first, but learning to manage diabetes mellitus enables you to start taking control of your condition, reducing the risk of further diabetes complications and improving your quality of life. Many healthcare professionals can help...

Read More

NCHS: Adult obesity and diabetes on the rise in the United States

Obesity and diabetes are significantly more common in the United States than 20 years ago, according to recent data from the National Center for Health Statistics (NCHS). In 1997, under 20 percent of American adults over 20 years of age were classified as obese, a figure that rose to 31.4 percent...

Read More

Top 5 Significant New Diabetes Drugs and Treatments in 2017

Diabetes is one of the most prevalent conditions in the United States, with figures from the Centers for Disease Control and Prevention suggesting almost one in ten people live with the condition, the equivalent to 30 million people across the country.  The majority of cases - nine out of ten...

Read More

Two type 2 diabetes drugs from Merck and Pfizer gain FDA approval

Pharmacies in the United States will soon stock two more medications for treating type 2 diabetes after pharmaceutical giants Merck and Pfizer had a pair of products approved by the US Food and Drug Administration (FDA). Steglujan (ertugliflozin and sitagliptin) and Steglatro (ertugliflozin) were...

Read More

Fiasp: New Rapid-Acting Mealtime Insulin Approved by FDA

Adults with type 1 or type 2 diabetes have a new treatment option available to them following the US Food and Drug Administration’s (FDA) decision to approve Novo Nordisk's rapid-acting mealtime insulin Fiasp (insulin aspart).  The drug is indicated to improve glycemic control in adults...

Read More

Merck diabetes drug Lusduna Nexvue gains tentative FDA approval

Pharmaceutical giant Merck has been granted tentative approval for Lusduna Nexvue (insulin glargine injection) 100 units/mL by the US Food and Drug Administration.  The follow-on biologic basal insulin comes in a pre-filled dosing device and will be used to treat patients with type 2...

Read More

Diabetic patients warned about NovoPen Echo recall

Novo Nordisk has announced a recall of six batches of the insulin cartridge holders used in its NovoPen Echos due to the possibility they will crack or break when exposed to certain chemicals. The company revealed some cleaning agents may contain agents that could leave the device susceptible to...

Read More

Teva's generic Vytorin brings cheaper statin to US patients

A generic version of the cholesterol-lowering medication Vytorin has been launched by Teva Pharmaceutical Industries, bringing another cheaper statin medication to US pharmacies. Vytorin is an HMG-COA reductase inhibitor/statin with a lipid modifying agent developed by Merck.  IMS data from...

Read More